Shine a Light

Shine A Light is a biotechnology company dedicated to developing transformative therapies for patients with Neurofibromatosis type 1 (NF1) and other rare genetic disorders. The company focuses on identifying and advancing novel therapeutic candidates that address the underlying genetic causes of NF1, including both small molecule and gene therapy approaches. By leveraging deep expertise in rare disease biology and a patient-centric development model, Shine A Light aims to fill the significant unmet medical need in the NF community. The company's strategy involves rigorous pre-clinical validation of targets to ensure a robust pipeline of potential treatments for various manifestations of the disease.